Keros Therapeutics (KROS) Current Leases (2019 - 2025)
Keros Therapeutics (KROS) posted Current Leases of $2.4 million for Q4 2025, up 3.88% on a QoQ basis from $2.3 million in Q3 2025, and up 21.74% year-over-year from $2.0 million in Q4 2024.
Keros Therapeutics (KROS) Current Leases (2019 - 2025) Analysis & Trends
Keros Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $2.4 million for Q4 2025.
- Quarterly Current Leases rose 21.74% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (up 21.74% YoY) and the FY2025 annual result came in at $2.4 million, up 21.74% from the prior year.
- Current Leases was $2.4 million for Q4 2025 at Keros Therapeutics, up from $2.3 million in the prior quarter.
- Across five years, Current Leases topped out at $2.4 million in Q4 2025 and bottomed at $436000.0 in Q1 2021.
- A 5-year average of $1.2 million and a median of $944500.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases tumbled 47.22% — and 2024, when it soared 203.93%.
- Keros Therapeutics' Current Leases stood at $862000.0 in 2021, then tumbled by 47.22% to $455000.0 in 2022, then soared by 120.88% to $1.0 million in 2023, then surged by 96.82% to $2.0 million in 2024, then climbed by 21.74% to $2.4 million in 2025.
- Business Quant data shows KROS's Current Leases at $2.4 million in Q4 2025, $2.3 million in Q3 2025, and $2.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | 2.32 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 611,000.00 |
| Dec 31, 2022 | 455,000.00 |
| Sep 30, 2022 | 455,000.00 |
| Jun 30, 2022 | 670,000.00 |
| Mar 31, 2022 | 884,000.00 |
| Dec 31, 2021 | 862,000.00 |
| Sep 30, 2021 | 843,000.00 |
| Jun 30, 2021 | 449,000.00 |
| Mar 31, 2021 | 436,000.00 |
| Dec 31, 2020 | 423,000.00 |
| Sep 30, 2020 | 412,000.00 |